The majority of ocular infections in the industrialized countries arise after surgical interventions. An appropriate antibacterial prophylaxis is therefore highly desirable in eye surgery. We used high performance liquid chromatography (HPLC) to measure the concentrations reached by imipenem, a modern wide-spectrum beta-lactam antibiotic, in plasma and aqueous humor of 26 patients scheduled for cataract surgery. Even a single 500 mg dose of imipenem achieved therapeutic levels of the molecule for the most common ophthalmic pathogens (1μg/ml or above) in the aqueous humor within one to two hours after administration. This drug may therefore be suitable for antibacterial prophylaxis in eye surgery.
AcarJ.F., GoldsteinF.W., KitzisM.D., GutmanL.Activity of imipenem on anaerobic bacteria.J Antimicrob Chemother1983; 12: 37–45.
4.
KesadoT., HashizumeT., AsahiY.Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.J Antimicrob Chemother1980; 17: 912–7.
5.
NeuH.C., LabthavikulP.Comparative of in vitro activity of N-formimidoyl thienamycin against Gram-positive and Gram-negative aerobic and anaerobic species and its betalactamase stability.J Antimicrob Chemother1982; 21: 180–7.
6.
DrusanoG.L.An overview of the pharmacology of imipenem/cilastatin.J Antimicrob Chemother1986; 18: 79–92.
7.
NorrbyS.R., AlestigK., FerberF.. Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehy-dropeptidase inhibitors.J Antimicrob Chemother1983; 23: 293–300.
8.
MianoL., VicentiniC., CarlucciG., BiordiL., GoldoniS., BolognaM.Imipenem concentrations in human prostatic tissue - clinical implications.Current Therapeutic Research1989; 46: 614–8.
9.
CarlucciG., BiordiL., VicentiniC., BolognaM.Determination of imipenem in human plasma, urine, and tissue by high performance liquid chromatography.J Pharm Biomed Anal1990; 8: 283–6.
10.
Gialdroni GrassiG.Breve rassegna sullo sviluppo di imipenem/cilastatina.Progressi in chemioterapia1989; 7: 5–16. (Suppl) G Ital Chemioter 35, 1989.
11.
JonesR.N.Review of the in vitro spectrum of activity of imipenem.Am J Med1985; 78: 22–32.
12.
ConciaE.Imipenem-cilastatina.Aggiornamenti in anti-bioticoterapia1989; 1: 4–32.
13.
KoulS., PhilipsonA., PhilipsonB.T.Incidence of endophthalmitis in Sweden.Acta Ophtalmol1989; 67: 499–503.
LaatikainenL., TarkkanenA.Management of purulent postoperative endophthalmitis.Ophthalmologica1986; 193: 34–8.
16.
LindquistT.D., SpikaJ.Gentamycin-resistant streptococcal endophthalmitis after keratoplasty.Cornea1990; 9: 88–90.
17.
PanjwaniN., ClarkB., CohenM., BarzaM., BaumJ.Differential binding of P. aeruginosa and S. aureus to corneal epithelium in culture.Invest Ophthalm Vis Sci1990; 31: 696–701.
GilbertC.M., NovakM.A.Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant.Am J Ophthalmol1984; 97: 593–5.
